Michael Schirner

PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.

J M Wood, Guido Bold, Elisabeth Buchdunger et al. · PubMed · 2000 · 846 citations

Immunology, Oral Administration, Pharmacotherapy +20

Concurrent Induction of Lymphangiogenesis, Angiogenesis, and Macrophage Recruitment by Vascular Endothelial Growth Factor-C in Melanoma

Mihaela Skobe, Leena M. Hamberg, Thomas Hawighorst et al. · American Journal Of Pathology · 2001 · 387 citations · Full text

Angiogenesis, Medicine, Concurrent Induction +7

Effects of Interferon Alpha on Vascular Endothelial Growth Factor Gene Transcription and Tumor Angiogenesis

Zofia von Marschall, A Scholz, Thorsten Cramer et al. · JNCI Journal of the National Cancer Institute · 2003 · 324 citations · Full text

The Virtual Brain Integrates Computational Modeling and Multimodal Neuroimaging

Petra Ritter, Michael Schirner, Anthony R. McIntosh et al. · Brain Connectivity · 2013 · 287 citations · Full text

Brain Simulator, Virtual Brain, Cognitive Science +15

Dendritic polyglycerol sulfates as multivalent inhibitors of inflammation

Jens Dernedde, Alexandra Rausch, Marie Weinhart et al. · Proceedings of the National Academy of Sciences · 2010 · 266 citations · Full text

Inflammation, Cell-based Drug Delivery, Anti-inflammatory +13